Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

17

Revenue 2017

Allergan

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Allergan's 2013 CNS (central nervous system) sales performance.

Amgen buys Danish partner Nuevolution for $167m

Amgen buys Danish partner Nuevolution for $167m It’s worth noting that RORγt inhibitors have a somewhat chequered history , with AstraZeneca and Allergan both having recent failed programmes in this category (AZD0284 and AGN-242428, respectively).

Pfizer’s alliance with Sosei Heptares bears first fruit

Pfizer’s alliance with Sosei Heptares bears first fruit Pfizer is just one of Sosei Heptares’ big pharma partners, and the company has also attracted sizeable collaborations with AstraZeneca, Allergan, Novartis, and Daiichi-Sankyo.

CHMP nod for Alexion, GSK drugs, revocation for Lartruvo

CHMP nod for Alexion, GSK drugs, revocation for Lartruvo Nuceiva (botulinum toxin type a), a facial filler for vertical lines between the eyebrows, a new rival for Allergan’s Botox.

Gilead's NASH drug fails again

Gilead's NASH drug fails again A number of other major pharma players such as Pfizer, Novartis, Allergan, Merck &Co and BMS are pursuing a treatment for NASH however, making Gilead far from alone in trying to

Allergan wins support against dissident shareholders

Allergan wins support against dissident shareholders Shareholders vote on 1 May. Allergan and its under-attack chief executive and chairman Brent Saunders has received some welcome support again what it calls ‘dissident’ shareholders. ... Allergan has also taken other measures to placate investor

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Behavioural Science in Healthcare
Personal health and wellbeing has never been more a part of the public conscious than it is now....
Why aren't doctors using digital therapeutics?
The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these...
Dec PME cover
Creativity in storytelling: why pharma must invest more in creativity
Chris Ross explores the value, the art and the much-rumoured death of creativity...

Infographics